meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to determine the safety and mechanisms of SGLT2 inhibition
in individuals on peritoneal dialysis (PD) with residual kidney function (RKF).